Jay R. Luly - Sep 15, 2021 Form 4 Insider Report for ENANTA PHARMACEUTICALS INC (ENTA)

Signature
/s/ Nathanial S. Gardiner as attorney-in-fact
Stock symbol
ENTA
Transactions as of
Sep 15, 2021
Transactions value $
-$266,698
Form type
4
Date filed
9/17/2021, 05:17 PM
Next filing
Nov 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENTA Common Stock Sale -$267K -4.52K -0.66% $59.06 677K Sep 15, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in December 2020.
F2 The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $59.00 to $59.23, inclusive.

Remarks:

The reporting person undertakes to provide to Enanta Pharmaceuticals, Inc., any security holder of Enanta Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 above.